MediClin AG

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: DE0006595101
EUR
3.78
-1.75 (-31.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
748.75
730.07
704.70
673.14
659.86
673.09
645.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
748.75
730.07
704.70
673.14
659.86
673.09
645.11
Raw Material Cost
642.37
682.09
640.51
619.19
612.20
604.70
532.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
466.33
460.60
436.33
423.40
422.19
412.58
391.29
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
22.69
22.55
10.62
9.33
9.58
9.21
3.47
Selling and Distribution Expenses
65.92
70.03
62.30
56.32
58.64
59.32
106.92
Other Expenses
-48.90
-48.32
-44.70
-43.27
-43.18
-42.18
-39.48
Total Expenditure (Excl Depreciation)
708.29
752.12
702.80
675.52
670.84
664.03
639.89
Operating Profit (PBDIT) excl Other Income
40.5
-22.1
1.9
-2.4
-11
9.1
5.2
Other Income
14.34
35.92
18.51
14.15
10.47
1.31
2.87
Operating Profit (PBDIT)
105.09
99.87
91.80
85.43
76.84
91.99
37.62
Interest
22.69
22.55
10.62
9.33
9.58
9.21
3.47
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
106.39
47.98
64.19
53.94
47.66
68.39
112.13
Depreciation
50.28
86.01
71.40
73.66
77.35
71.17
22.29
Profit Before Tax
32.12
-8.69
9.78
2.45
-10.09
11.61
11.86
Tax
7.21
2.04
0.06
0.96
-1.05
1.93
4.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
24.84
-10.78
9.44
1.46
-9.00
9.66
7.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
24.84
-10.78
9.44
1.46
-9.00
9.66
7.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.07
0.05
0.28
0.02
-0.04
0.02
0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
24.91
-10.72
9.72
1.49
-9.03
9.68
7.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
222.51
195.92
209.21
183.28
177.16
190.99
191.61
Earnings per share (EPS)
0.52
-0.23
0.2
0.03
-0.19
0.2
0.16
Diluted Earnings per share
0.52
-0.23
0.2
0.03
-0.19
0.2
0.16
Operating Profit Margin (Excl OI)
5.4%
-3.02%
0.27%
-0.35%
-1.66%
2.9%
1.93%
Gross Profit Margin
11.01%
10.59%
11.52%
11.31%
10.19%
12.3%
5.29%
PAT Margin
3.32%
-1.48%
1.34%
0.22%
-1.36%
1.44%
1.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 2.56% vs 3.60% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 332.71% vs -210.31% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 41.72% vs -12.69% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 0.44% vs 113.21% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of MediClin AG With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
748.75
1,826.92
-1,078.17
-59.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
748.75
1,826.92
-1,078.17
-59.02%
Raw Material Cost
642.37
1,656.11
-1,013.74
-61.21%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
466.33
1,057.99
-591.66
-55.92%
Power Cost
0
0
0.00
Manufacturing Expenses
22.69
3.14
19.55
622.61%
Selling and Distribution Expenses
65.92
159.16
-93.24
-58.58%
Other Expenses
-48.90
-106.11
57.21
53.92%
Total Expenditure (Excl Depreciation)
708.29
1,815.27
-1,106.98
-60.98%
Operating Profit (PBDIT) excl Other Income
40.47
11.65
28.82
247.38%
Other Income
14.34
51.51
-37.17
-72.16%
Operating Profit (PBDIT)
105.09
125.58
-20.49
-16.32%
Interest
22.69
3.14
19.55
622.61%
Exceptional Items
0.00
-3.72
3.72
100.00%
Gross Profit (PBDT)
106.39
170.81
-64.42
-37.71%
Depreciation
50.28
62.62
-12.34
-19.71%
Profit Before Tax
32.12
56.09
-23.97
-42.73%
Tax
7.21
11.00
-3.79
-34.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
24.84
43.35
-18.51
-42.70%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
24.84
43.35
-18.51
-42.70%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.07
1.86
-1.79
-96.24%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
24.91
45.21
-20.30
-44.90%
Equity Capital
0
0
0.00
Face Value
0.00
2.50
0.00
Reserves
222.51
1,295.93
-1,073.42
-82.83%
Earnings per share (EPS)
0.52
0.65
-0.13
-20.00%
Diluted Earnings per share
0.52
0.65
-0.13
-20.00%
Operating Profit Margin (Excl OI)
5.40%
0.63%
0.00
4.77%
Gross Profit Margin
11.01%
6.50%
0.00
4.51%
PAT Margin
3.32%
2.37%
0.00
0.95%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 74.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.56% vs 3.60% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 2.49 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 332.71% vs -210.31% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.07 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 41.72% vs -12.69% in Dec 2023

Annual - Interest
Interest 2.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.44% vs 113.21% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.40%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023